Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Jenny Riga

BSc (Hons) Psychology, MSc Health Psychology, MBPsS

Infectious Diseases Research Facilitator

I am currently responsible for the regional trial management of PACE, ATAFUTI & RIVET.

PACE is a randomised controlled trial that aims to evaluate whether using a CRP point of care test (POCT) results in better targeting of antibiotic treatment than usual care informed by NICE and GOLD guidelines. The primary outcomes are the overall consumption of antibiotics for COPD and patient-rated clinical recovery from their AECOPD, with the aim being to reduce overall antibiotic use without compromising patient recovery.
The sponsor is the University of Cardiff. The Oxford University Primary Care Clinical Trials Unit is a coordinating center.

ATAFUTI aims to evaluate whether the herb, Uva ursi, or the advice to take a readily available anti-inflammatory provide relief from urinary symptoms in adult women with a suspected UTI. The interventions will be compared to determine whether they result in reduced antibiotic use in adult women with a suspected UTI and determine the patient / practitioner barriers to implementation of a delayed antibiotic prescription approach and use of herbal medication.
The sponsor is the University of Southampton. The Oxford University Primary Care Clinical Trials Unit is a coordinating center.

RIVET is a pilot study aiming to examine the feasibility and acceptability of the baseline and follow-up processes of INVICTUS; a large scale vaccine trial the Primary Care Clinical Trials Unit will be running next year.
The sponsor is Vaccitech.

True True